Hollywood

Hollywood is a neighborhood in Los Angeles, California that is situated west-northwest of Downtown Los Angeles. Due to its fame and cultural identity as the historical center of movie studios and movie stars, the word "Hollywood" is a metonym of American cinema, and people often use it interchangeably to refer to the greater Los Angeles area in general. The nicknames Star Struck Town and Tinsel Town refer to Hollywood and its movie industry. In 1853, one adobe hut stood in Nopalera, named for the Mexican Nopal cactus indigenous to the area. By 1870, an agricultural community flourished in the area with thriving crops of many common and exotic varieties. The residents called this area the Cahuenga Valley, after the pass in the Santa Monica Mountains immediately to the north. Soon thereafter, land speculation would lead to subdivision of the large plots and an influx of homeowners. Hollywood incorporated as a municipality on November 14, 1903. The vote was 88 for incorporation and 77 against it. On January 30, 1904, the voters in Hollywood decided, by a vote of 113 to 96, for the banishment of liquor in the city, except when it was for medicinal purposes. Neither hotels nor restaurants served wine or liquor before or after meals. By 1910, because of an ongoing struggle to secure an adequate water supply, town officials voted for Hollywood to annex into the City of Los Angeles for its water system. Los Angeles was a growing city and had opened the Los Angeles Aqueduct that was piping water down from the Owens River in the Owens Valley. Another reason for the vote was that Hollywood could have access to drainage through Los Angeles' sewer system. With annexation, the name of Prospect Avenue changed to Hollywood Boulevard and all the street numbers in the new district changed.

More Resources

INVESTMENT INTERESTS

SEC. 6002. TRANSPARENCY REPORTS AND REPORTING OF PHYSICIAN
OWNERSHIP OR INVESTMENT INTERESTS.
Part A of title XI of the Social Security Act (42 U.S.C. 1301 et
seq.) is amended by inserting after section 1128F the following new
section:
  SEC. 1128G o42 U.S.C. 1320a–7h.. TRANSPARENCY REPORTS AND REPORTING
OF PHYSICIAN OWNERSHIP OR INVESTMENT INTERESTS.
(a) TRANSPARENCY REPORTS.—
(1) PAYMENTS OR OTHER TRANSFERS OF VALUE.—
(A) IN GENERAL.—On March 31, 2013, and on the
90th day of each calendar year beginning thereafter, any
applicable manufacturer that provides a payment or other
transfer of value to a covered recipient (or to an entity or
individual at the request of or designated on behalf of a
covered recipient), shall submit to the Secretary, in such
electronic form as the Secretary shall require, the following
information with respect to the preceding calendar
year:
(i) The name of the covered recipient.
(ii) The business address of the covered recipient
and, in the case of a covered recipient who is a physician,
the specialty and National Provider Identifier of
the covered recipient.
(iii) The amount of the payment or other transfer
of value.
(iv) The dates on which the payment or other
transfer of value was provided to the covered recipient.
(v) A description of the form of the payment or
other transfer of value, indicated (as appropriate for
all that apply) as—
(I) cash or a cash equivalent;
(II) in-kind items or services;
(III) stock, a stock option, or any other ownership
interest, dividend, profit, or other return on
investment; or
(IV) any other form of payment or other
transfer of value (as defined by the Secretary).
(vi) A description of the nature of the payment or
other transfer of value, indicated (as appropriate for
all that apply) as—
(I) consulting fees;
(II) compensation for services other than consulting;
(III) honoraria;
(IV) gift;
(V) entertainment;
(VI) food;
(VII) travel (including the specified destinations);
(VIII) education;
(IX) research;
(X) charitable contribution;
(XI) royalty or license;
(XII) current or prospective ownership or investment
interest;
(XIII) direct compensation for serving as faculty
or as a speaker for a medical education program;
(XIV) grant; or
(XV) any other nature of the payment or
other transfer of value (as defined by the Secretary).
(vii) If the payment or other transfer of value is
related to marketing, education, or research specific to
a covered drug, device, biological, or medical supply,
the name of that covered drug, device, biological, or
medical supply.
(viii) Any other categories of information regarding
the payment or other transfer of value the Secretary
determines appropriate.